Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$57.56 - $82.54 $1,381 - $1,980
-24 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$93.66 - $139.27 $369,020 - $548,723
-3,940 Reduced 99.39%
24 $3,000
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $459,285 - $610,739
3,940 Added 16416.67%
3,964 $523,000
Q4 2020

Feb 09, 2021

BUY
$99.61 - $142.12 $2,390 - $3,410
24 New
24 $3,000
Q3 2020

Dec 10, 2020

SELL
$72.92 - $102.01 $221,312 - $309,600
-3,035 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $892 - $1,484
16 Added 0.53%
3,035 $264,000
Q1 2020

May 08, 2020

BUY
$37.9 - $104.44 $8,982 - $24,752
237 Added 8.52%
3,019 $175,000
Q4 2019

Feb 07, 2020

SELL
$77.66 - $99.74 $337,199 - $433,071
-4,342 Reduced 60.95%
2,782 $257,000
Q3 2019

Oct 29, 2019

BUY
$90.37 - $122.49 $643,795 - $872,618
7,124 New
7,124 $644,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Nvwm, LLC Portfolio

Follow Nvwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.